By:
On:
In: Daily gains
With: 0 Comments
Symbol Stock Price change today
BABA Alibaba Group Holding Limited A 3.59%
NVDA NVIDIA Corporation 3.07%
ALGN Align Technology Inc. 2.78%
AMAT Applied Materials Inc. 2.66%
BWLD Buffalo Wild Wings Inc. 1.95%
SWKS Skyworks Solutions Inc. 1.90%
IDXX IDEXX Laboratories Inc. 1.89%
TRN Trinity Industries Inc. 1.67%
HSKA Heska Corporation 1.66%
AAPL Apple Inc. 1.55%
ABMD ABIOMED Inc. 1.55%
SAM Boston Beer Company Inc. (The) 1.55%
FB Facebook Inc. 1.39%
MIDD The Middleby Corporation 1.25%
ALXN Alexion Pharmaceuticals Inc. 1.24%
LULU lululemon athletica inc. 1.21%
CVCO Cavco Industries Inc. 1.14%
GTN Gray Communications Systems In 1.11%
MET MetLife Inc. 1.00%
COF Capital One Financial Corporati 0.88%
STZ Constellation Brands Inc. 0.86%
LNCE Snyder’s-Lance Inc. 0.69%
MCK McKesson Corporation 0.64%
NFLX Netflix Inc. 0.59%
TMO Thermo Fisher Scientific Inc 0.58%
PCLN The Priceline Group Inc. 0.49%
AMZN Amazon.com Inc. 0.47%
SBUX Starbucks Corporation 0.34%
MNST Monster Beverage Corporation 0.30%
REGN Regeneron Pharmaceuticals Inc. 0.29%
EW Edwards Lifesciences Corporatio 0.25%
GWR Genesee & Wyoming Inc. Class A 0.21%
CRUS Cirrus Logic Inc. 0.17%
EXR Extra Space Storage Inc 0.15%
HDSN Hudson Technologies Inc. 0.13%
MEI Methode Electronics Inc. 0.13%
UA Under Armour Inc. Class C 0.12%
AZPN Aspen Technology Inc. 0.10%
GOOGL Alphabet Inc. -0.00%
HZO MarineMax Inc. (FL) -0.32%
SUI Sun Communities Inc. -0.34%
MRK Merck & Company Inc. (new) -0.41%
THRM Gentherm Inc -0.48%
ULTA Ulta Beauty Inc. -0.56%
HOG Harley-Davidson Inc. -0.58%
DPZ Domino’s Pizza Inc -0.69%
AYI Acuity Brands Inc (Holding Comp -1.06%
CBPO CHINA BIOLOGIC SHS -1.30%

By:
On:
In: Good company, Stock analysis
Tagged:
With: 0 Comments

Company name Alexion Pharmaceuticals, Inc.
Stock ticker ALXN
Live stock price [stckqut]ALXN[/stckqut]
P/E compared to competitors Good

MANAGEMENT EXECUTION

Employee productivity Good
Sales growth Good
EPS growth Good
P/E growth Good
EBIT growth Good

ANALYSIS

Confident Investor Rating Good
Target stock price (TWCA growth scenario) $213.93
Target stock price (averages with growth) $227.74
Target stock price (averages with no growth) $103.56
Target stock price (manual assumptions) $214.14

 

The following company description is from Google Finance: http://www.google.com/finance?q=alxn

Alexion Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of therapeutic products. The Company’s products include Soliris (eculizumab), Strensiq (asfotase alfa) and Kanuma (sebelipase alfa). The Company’s clinical development programs include Soliris (eculizumab), cPMP (ALXN1101), SBC-103, ALXN1210 (IV) and ALXN1210 (Subcutaneous). Its Soliris is the therapeutic approved for patients with either paroxysmal nocturnal hemoglobinuria (PNH) or hemolytic uremic syndrome (aHUS). PNH and aHUS result from chronic uncontrolled activation of the complement component of the immune system. Its Strensiq is for the treatment of patients with Hypophosphatasia (HPP). Its product, Kanuma is for the treatment of patients with Lysosomal Acid Lipase Deficiency (LAL-D). It is a recombinant form of the human LAL enzyme, which is a replacement therapy that is approved for the treatment for patients with LAL-D.

 

Confident Investor comments: At this price and at this time, I think that a Confident Investor can confidently invest in Alexion Pharmaceuticals, Inc.

If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor. You can review the best companies that I have found (and I probably invest my own money in most of these companies) in my Watch List.

How was this analysis of Alexion Pharmaceuticals, Inc. calculated?

For owners of my book, “The Confident Investor” I offer the following analysis (you must be logged in to this site as a book owner in order to see the following analysis). If you have registered and cannot see the balance of this article, make sure you are logged in and refresh your browser.
[s2If current_user_can(access_s2member_level1)]

In order to assist you in using the techniques of this book, the values that I used when calculating the Manual pricing above were:

  • Stock price at the time of the calculation: $138.33
  • Growth: 0.2
  • Current EPS (TTM): $2.31
  • P/E: 60
  • Future EPS Calc: $5.74
  • Future Stock Price Calc: $344.88
  • Target stock price: $214.14

[/s2If]
I hope that this makes you a Confident Investor.

By:
On:
In: Good company, Stock analysis
Tagged:
With: 0 Comments

Company name Align Technology, Inc.
Stock ticker ALGN
Live stock price [stckqut]ALGN[/stckqut]
P/E compared to competitors Fair

MANAGEMENT EXECUTION

Employee productivity Poor
Sales growth Good
EPS growth Good
P/E growth Good
EBIT growth Good

ANALYSIS

Confident Investor Rating Good
Target stock price (TWCA growth scenario) $268.51
Target stock price (averages with growth) $296.76
Target stock price (averages with no growth) $134.74
Target stock price (manual assumptions) $269.77

The following company description is from Google Finance: http://www.google.com/finance?q=algn
Align Technology, Inc. designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and computer-aided design/computer-aided manufacturing (CAD/CAM) digital services used in dentistry, orthodontics and dental records storage. The Company operates through two segments: Clear Aligner segment and Scanner and Services (Scanner) segment. The Clear Aligner segment consists of its Invisalign System, which includes Invisalign Full, Teen and Assist (Comprehensive Products), Express/Lite (Non-Comprehensive Products) and Vivera Retainers, along with its training and ancillary products for treating malocclusion (Non-Case). The Scanner segment consists of intra-oral scanning systems and other services available with the intra-oral scanners that provide digital alternatives to the traditional cast models. The Scanner segment includes its iTero scanner and OrthoCAD services.

 

Confident Investor comments: At this price and at this time, I think that a Confident Investor can confidently invest in Align Technology, Inc.

If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor. You can review the best companies that I have found (and I probably invest my own money in most of these companies) in my Watch List.

How was this analysis of Align Technology, Inc. calculated?

For owners of my book, “The Confident Investor” I offer the following analysis (you must be logged in to this site as a book owner in order to see the following analysis). If you have registered and cannot see the balance of this article, make sure you are logged in and refresh your browser.
[s2If current_user_can(access_s2member_level1)]

In order to assist you in using the techniques of this book, the values that I used when calculating the Manual pricing above were:

  • Stock price at the time of the calculation: $174.05
  • Growth: 0.2
  • Current EPS (TTM): $2.91
  • P/E: 60
  • Future EPS Calc: $7.24
  • Future Stock Price Calc: $434.46
  • Target stock price: $269.76

[/s2If]
I hope that this makes you a Confident Investor.

By:
On:
In: Good company, Stock analysis
Tagged:
With: 0 Comments

Company name ABIOMED, Inc.
Stock ticker ABMD
Live stock price [stckqut]ABMD[/stckqut]
P/E compared to competitors Fair

MANAGEMENT EXECUTION

Employee productivity Fair
Sales growth Good
EPS growth Good
P/E growth Good
EBIT growth Good

ANALYSIS

Confident Investor Rating Good
Target stock price (TWCA growth scenario) $237.
Target stock price (averages with growth) $262.38
Target stock price (averages with no growth) $119.66
Target stock price (manual assumptions) $47.28

 

The following company description is from Google Finance: http://www.google.com/finance?q=abmd

ABIOMED, Inc. is a provider of temporary percutaneous mechanical circulatory support devices. The Company offers care to heart failure patients. The Company operates in the segment of the research, development and sale of medical devices to assist or replace the pumping function of the failing heart. The Company develops, manufactures and markets products that are designed to enable the heart to rest, heal and recover by improving blood flow to the coronary arteries and end-organs and/or temporarily performing the pumping function of the heart. The Company’s product portfolio includes the Impella 2.5, Impella CP, Impella RP, Impella LD, Impella 5.0 and AB5000. The Company’s products are used in the cardiac catheterization lab (cath lab), by interventional cardiologists, the electrophysiology lab, the hybrid lab and in the heart surgery suite by heart surgeons.

 

Confident Investor comments: At this price and at this time, I think that a Confident Investor can confidently invest in ABIOMED, Inc.

If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor. You can review the best companies that I have found (and I probably invest my own money in most of these companies) in my Watch List.

How was this analysis of ABIOMED, Inc. calculated?

For owners of my book, “The Confident Investor” I offer the following analysis (you must be logged in to this site as a book owner in order to see the following analysis). If you have registered and cannot see the balance of this article, make sure you are logged in and refresh your browser.
[s2If current_user_can(access_s2member_level1)]

In order to assist you in using the techniques of this book, the values that I used when calculating the Manual pricing above were:

  • Stock price at the time of the calculation: $152.98
  • Growth: 0.2
  • Current EPS (TTM): $1.7
  • P/E: 18
  • Future EPS Calc: $4.23
  • Future Stock Price Calc: $76.14
  • Target stock price: $47.27

[/s2If]
I hope that this makes you a Confident Investor.

By:
On:
In: Fair company, Stock analysis
Tagged:
With: 0 Comments

Company name Apple Inc.
Stock ticker AAPL
Live stock price [stckqut]AAPL[/stckqut]
P/E compared to competitors Good

MANAGEMENT EXECUTION

Employee productivity Good
Sales growth Fair
EPS growth Fair
P/E growth Fair
EBIT growth Fair

ANALYSIS

Confident Investor Rating Fair
Target stock price (TWCA growth scenario) $191.14
Target stock price (averages with growth) $177.56
Target stock price (averages with no growth) $89.8
Target stock price (manual assumptions) $181.

The following company description is from Google Finance: http://www.google.com/finance?q=aapl

Apple Inc. (Apple) designs, manufactures and markets mobile communication and media devices, personal computers, and portable digital music players, and a variety of related software, services, peripherals, networking solutions, and third-party digital content and applications. The Company’s products and services include iPhone, iPad, Mac, iPod, Apple TV, a portfolio of consumer and professional software applications, the iOS and OS X operating systems, iCloud, and a variety of accessory, service and support offerings. The Company also delivers digital content and applications through the iTunes Store, App StoreSM, iBookstoreSM, and Mac App Store. The Company distributes its products worldwide through its retail stores, online stores, and direct sales force, as well as through third-party cellular network carriers, wholesalers, retailers, and value-added resellers. In February 2012, the Company acquired app-search engine Chomp.

 

Confident Investor comments: At this time, I think that a Confident Investor can cautiously invest in Apple Inc. as long as the price is correct. Most of the fundamentals of this company are good but there are some concerns.

If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor. You can review the best companies that I have found (and I probably invest my own money in most of these companies) in my Watch List.

How was this analysis of Apple Inc. calculated?

For owners of my book, “The Confident Investor” I offer the following analysis (you must be logged in to this site as a book owner in order to see the following analysis). If you have registered and cannot see the balance of this article, make sure you are logged in and refresh your browser.
[s2If current_user_can(access_s2member_level1)]

In order to assist you in using the techniques of this book, the values that I used when calculating the Manual pricing above were:

  • Stock price at the time of the calculation: $157.11
  • Growth: 0.13
  • Current EPS (TTM): $8.79
  • P/E: 18
  • Future EPS Calc: $16.19
  • Future Stock Price Calc: $291.51
  • Target stock price: $181

[/s2If]
I hope that this makes you a Confident Investor.